miR-124 Upregulation as a new therapeutic strategy: the evolving role of obefazimod in ulcerative colitis

Current Opinion in Pharmacology 2026

View at publisher
Authors: Viviana Parra-Izquierdo, Virginia Solitano, Bram Verstockt
DOI: 10.1016/j.coph.2026.102659
Cited by: 1
References: 26

Fields of Study & Subjects

Inflammatory Bowel Disease MicroRNA in disease regulation Barrier Structure and Function Studies

Publication details

Journal / source
Current Opinion in Pharmacology
Publisher
Elsevier BV
Volume
91
Pages
102659–102659
Publication date
1 August 2026
Language
EN